Antibiotice (BSE:ATB) Inventories, Raw Materials & Components: lei79.5 Mil (As of Mar. 2026)


BSE:ATB Antibiotice SA BSE:ATB
75 GF Score
Price lei2.19
GF Value lei2.19
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Antibiotice Inventories, Raw Materials & Components?

Antibiotice BSE:ATB +1.86% 75 Inventories, Raw Materials & Components is lei79.5 Mil as of Mar. 2026. GuruFocus rates BSE:ATB with a GF Score™ of 75/100 and a GF Value™ of lei2.19 (Fairly Valued). The stock has 6 warning signs investors should review.

Antibiotice's inventories, raw materials & components for the quarter that ended in Mar. 2026 was lei79.5 Mil.

Antibiotice's quarterly raw materials declined from Sep. 2025 (lei66.0 Mil) to Dec. 2025 (lei65.8 Mil) but then increased from Dec. 2025 (lei65.8 Mil) to Mar. 2026 (lei79.5 Mil).

Antibiotice's annual raw materials increased from Dec. 2023 (lei66.9 Mil) to Dec. 2024 (lei71.1 Mil) but then declined from Dec. 2024 (lei71.1 Mil) to Dec. 2025 (lei65.8 Mil).

Antibiotice Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Antibiotice's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Antibiotice Inventories, Raw Materials & Components Chart

Antibiotice Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 41.64 55.86 66.87 71.06 65.81

Antibiotice Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 67.21 64.04 66.03 65.81 79.49
BSE:ATB
75GF Score
Antibiotice SA BSE:ATB
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Antibiotice Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of lei79.5 Mil mean?
Antibiotice (BSE:ATB) has a Inventories, Raw Materials & Components of lei79.5 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on Antibiotice and its competitors.
Is Antibiotice's Inventories, Raw Materials & Components too high?
Antibiotice's current Inventories, Raw Materials & Components is lei79.5 Mil. Overall, Antibiotice has a GF Score™ of 75/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Antibiotice's Inventories, Raw Materials & Components compare to ZTS and UTHR?
Antibiotice's Inventories, Raw Materials & Components of lei79.5 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Drug Manufacturers company?
A good Inventories, Raw Materials & Components depends on the Drug Manufacturers industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Antibiotice and its competitors. Antibiotice's current Inventories, Raw Materials & Components is lei79.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Antibiotice stock overvalued right now?
Based on GuruFocus' analysis, Antibiotice (BSE:ATB) is currently considered Fairly Valued. The stock's GF Value™ is lei2.19, compared to a current price of lei2.19 — trading right at its estimated fair value. The current Inventories, Raw Materials & Components is lei79.5 Mil. Antibiotice's overall GF Score™ is 75/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Antibiotice (BSE:ATB), the current Inventories, Raw Materials & Components is lei79.5 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Antibiotice (BSE:ATB) Overvalued in 2026?

Based on GuruFocus' analysis, Antibiotice stock appears to be undervalued. The current stock price of lei2.19 is trading 0% below its estimated GF Value™ of lei2.19. GuruFocus considers Antibiotice to be Fairly Valued.

Key valuation signals for BSE:ATB:

  • Inventories, Raw Materials & Components: lei79.5 Mil
  • GF Value™: lei2.19 vs. price of lei2.19 (0% below fair value)
  • GF Score™: 75/100 with 6 warning signs

No single metric tells the full story. See the BSE:ATB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Antibiotice Business Description

Address 1 Valea Lupului Street, Iasi, ROU, 707410
Antibiotice SA is a Romania based company engaged in manufacturing generic medicines. It primarily develops and produces generic medicines for human use, veterinary medicines and active substance Nystatin. The group's generic medicines are primarily targeted at patients with infections, dermatological, cardiovascular, digestive tract diseases or diseases of the musculoskeletal system. It manufactures firm powders for solutions for injection and suspensions for injection (penicillins), capsules, tablets, suppositories and topical preparations (ointments, gels, creams).
75GF Score

Get the complete analysis for BSE:ATB

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

lei2.19
Price
lei2.19
GF Value